Summary
X-linked Charcot-Marie-Tooth disease (CMTX) is caused by mutations in the gap junction gene connexin32 (Cx32). To date, 89 different mutations have been found, including deletions, insertions, missense, and nonsense mutations, and at least two mutations in the non-coding region. Different mutations appear to have different effects on the synthesis and localization of Cx32 protein. Both myelinating Schwann cells and oligodendrocytes express Cx32 mRNA and protein, and the localization of Cx32 protein matches the location of putative gap junctions previously seen by freeze-fracture electron microscopy. In myelinating Schwann cells, Cx32 protein is found in incisures and paranodes. Preliminary data suggest that gap junctions form a radial channel that directly traverses the myelin sheath. It is plausible that mutations in Cx32 disrupt the gap junctions in the myelin sheath, thereby abolishing this radial pathway and leading to peripheral neuropathy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Allan W (1939): Relation of hereditary pattern to clinical severity as illustrated by peroneal atrophy. Arch Int Med 63: 1123â1131.
Barrio LC, Suchyna T, Bargiello T, Xu LX, Roginski RS, Bennett MVL, Nicholson BJ (1991): Gap junctions formed by connexins 26 and 32 alone and in combination are differently affected by applied voltage. Proc Natl Acad Sci USA 88: 8410â8414.
Beckett J. Holden JJA, Simpson NE, White BN, MacLeod PM (1986): Localization of X-linked dominant Charcot-Marie-Tooth disease (CMT2) to Xq13. J Neurogenet 3: 225â231.
Bennett MVL. Barrio LC, Bargiello TA, Spray DC, Hertzberg E, Saez JC (1991): Gap junctions: new tools, new answers, new questions. Neuron 6: 305â320.
Bergoffen J, Scherer SS. Wang S. Oronzi-Scott M, Bone L, Paul DL, Chen K. Lensch MW. Chance P, Fischbeck K (1993a): Connexin mutations in X-linked Charcot-Marie-Tooth disease. Science 262: 2039â2042.
Bergoffen J. Trofatter J, Pericak-Vance MA. Haines J, Chance PF, Fischbeck KB (1993b): Linkage localization of X-linked Charcot-Marie-Tooth disease. Am J Hum Genet 52: 312â318.
Bone LJ, Dahl N. Lensch MW, Chance PF, Kelly T. Le Guern E, Magi S. Parry G, Shapiro H. Wang S. Fischbeck KB (1995a): New Connexin32 mutations associated with X-linked Charcot-Marie-Tooth disease. Neurology 45: 1863â1866.
Bone LJ, Scherer SS, Balice-Gordon RJ, Paul DL, Fischbeck KH (1995b): The disease mechanism for X-linked Charcot-Marie-Tooth disease. Am J Hum Genet 57: A236.
Bone Li, Scherer SS, Balice-Gordon R (1996): The role of the gap junction protein Connexin32 in myelinating Schwann cells. Soc Neurosci Abstr 22: 1980.
Bruzzone R, T.W. White, S.S. Scherer, Fischbeck KH, Paul DL (1994): Null mutations of Connexin32 in patients with X-linked Charcot-Marie-Tooth disease. Neuron 13: 1253â1260.
Bruzzone R. White TW. Paul DL (1996): Connections with connexins: the molecular basis of direct intercellular signaling. Eur J Biochem 238: 1â27.
Chance PF (1997): Inherited demyelinating neuropathy: Charcot-Marie-Tooth disease and related disorders. In Rosenberg RN, Prusiner SB, DiMauro S, Barchi RL. The Molecular and Genetic Basis of Neurological Disease.â Butterworth-Heinemann: 807â816.
Cochrane S, Bergoffen J, Fairweather ND, MĂŒller E, Mostaccuiolo ML, Monaco AP. Fischbeck KB. Haites NE (1994): X-linked Charcot-Marie-Tooth disease (CMTXI)-A study of 15 families with 12 highly informative polymorphisms. J Med Genet 31: 193â196.
Cowchock RS, Duckett SW. Streletz LJ, Graziani LJ, Jackson LG (1985): X-linked sensory-motor neuropathy type 11 with deafness and mental retardation: a new disorder. Am J Hum Genet 20: 307â315.
Dahl G, Miller T, Paul D, Voellmy R (1987): Expression of functional cell-cell channels from cloned rat liver junction complementary DNA. Science 236: 1290â1293.
Dahl G. Nonner W, Werner R (1994): Attempts to define functional domains of gap junction proteins with synthetic peptides. Biophys J 67: 1816â1822.
Dahl G, Werner R. Levine E. Rabadan-Diehl C (1992): Mutational analysis of gap junction formation. Biophys J 62: 172â182.
de Waegh SM, Lee VM-Y. Brady ST (1992): Local modulation of neurofilament phosphorvlation. axonal caliber. and slow axonal transport by myelinating Schwann cells. Cell 68: 451â463.
de Weerdt CJ (1978): Charcot-Marie-Tooth disease with sex-linked inheritance, linkage studies and abnormal serum alkaline phosphatase levels. Fur Neurol 17: 336â344.
Dermietzel R, Traub O, Hwang TK, Beyer E, Bennett MVL, Spray DC, Willecke K (1989): Differential expression of three gap junction proteins in developing and mature brain tissues. Proc Natl Acad Sci USA 86: 10148â10152.
Doyle JP, Colman DR (1993): Glial-neuron interactions and the regulation of myelin formation. Curr Opin Cell Biol 5: 779â785.
Dyck PJ, Chance P, Lebo R, Carney JA (1993): Hereditary motor and sensory neuropathies. In Dyck PJ, Thomas PK. Griffin,IW, Low PA and Poduslo JF. âPeripheral Neuropathy, 3rd Edn.â Philadelphia: W.B. Saunders, pp 1094â1136.
Dyck PJ, Lambert EH (1968a): Lower motor and primary sensory neuron diseases with peroneal muscular atrophy. I. Neurologic, genetic and electrophysiologic findings in hereditary polyneuropathies. Arch Neurol 18: 603â6 18.
Dyck PJ, Lambert EH (1968b): Lower motor and primary sensory neuron diseases with peroneal muscular atrophy. II. Neurologic, genetic and electrophysiologic findings in various neuronal degenerations. Arch Neurol 18: 619â625.
Erwin WG (1944): A pedigree of sex-linked recessive peroneal atrophy. J Hered 35: 24â26.
Fain PR, Barker DF, Chance PF (1994): Refined genetic mapping of X-linked Charcot-Marie-Tooth neuropathy. Am J Hum Genet 54: 229â235.
Fairweather N, Bell C, Cochrane S, Chelly J, Wang S, Mostacciuolo ML, Monaco AP, Haites NE (1994): Mutations in the connexin 32 gene in X-linked dominant Charcot-Marie-Tooth disease ( CMT-Xl ). Hum Mol Genet 3: 29â34.
Fischbeck KF, Ritter A, Shi Y (1990): X-linked recessive and X-linked dominant Charcot-Marie-Tooth disease. In Lovelace RE and Shapiro HK. âCharcot-Marie-Tooth diseorders: Pathophysiology, Molecular Genetics, and Therapy.â New York: Wiley-Liss, pp 335â341.
Fischbeck KH, ar-Rushdi N, Pericak-Vance M, Rozear M, Roses AD, Fryns JP (1986): X-linked neuropathy: gene localization with DNA probes. Ann Neurol 20: 527â532.
Fryns JP, Van den Berghe H (1980): Sex-linked recessive inheritance in Charcot-Marie-Tooth disease with partial clinical manifestation in female carriers. Hum Genet 55: 413â415.
Gabreels-Festen AAWM, Joosten EMG, Gabreels FJM, Jennekens FGI, Kempen TWJ (1992): Early morphological features in dominantly inherited demyelinating motor and sensory neuropathy (HMSN Type-1). J Neurol Sci 107: 145â154.
Gal A, Mucke J, Theile H, Wieacker PF, Ropers HH, Wienker TF (1985): X-linked dominant Charcot-Marie-Tooth disease: suggestion of linkage with a cloned DNA sequence from the proximal Xq. Hum Genet 70: 38â42.
Goonewardena P, Welinhinda J, Anvret M, Gyftodimou J, Haegermark A, Iselius L, Lindsten J, Pettersson U (1988): A linkage study of the locus for X-linked Charcot-Marie-Tooth disease. Clin Genet 33: 435â440.
Gow A, Lazzarini RA (1996): A cellular mechanism governing the severity of Pelizaeus-Merbacher disease. Nat Genet 13: 422â427.
Hahn AF, Brown WF, Koopman WJ, Feasby TE (1990): X-linked dominant hereditary motor and sensory neuropathy. Brain 113: 1511â1525.
Haites N, Fairweather N, Clark C, Kelly KF, Simpson S, Johnston AW (1989): Linkage in a family with X-linked Charcot-Marie-Tooth disease. Clin Genet 35: 399â403.
Harding AE, Thomas PK (1980a): The clinical features of hereditary motor and sensory neuropathy types I and II. Brain 103: 259â280.
Harding AE, Thomas PK (1980b): Genetic aspects of hereditary motor and sensory neuropathy (types I and II). J Med Genet 176: 329â336.
Herringham WP (1889): Muscular atrophy of the peroneal type affecting many members of a family. Brain 11: 230â236.
Ionasescu V, Ionasescu R, Searby C (1996a): Correlation between connexin 32 gene mutations and clinical phenotype in X-linked dominant Charcot-Marie-Tooth neuropathy. Am J Med Genet 63: 486â491.
Ionasescu VV, Searby C, Ionasescu R, Neuhaus IM, Werner R (1996b): Mutations of noncoding region of the connexin32 gene in X-linked dominant Charcot-Marie-Tooth neuropathy. Neurology 47: 541â544.
Ionasescu V, Searby C, lonasescu R (1994): Point mutations of the connexin32 ( GJBI) gene in X-linked dominant Charcot-Marie-Tooth neuropathy. Hum Mol Genet 3: 355â358.
Ionasescu VV, Burns TL, Searby C,Ionasescu R (1988): X-linked dominant Charcot-Marie-Tooth neuropathy with 15 cases in a family: genetic linkage study. Muscle Nerve 11: 435â440.
Ionasescu VV, Ionasescu R, Searby C (1993): Screening of dominantly inherited Charcot-Marie-Tooth neuropathies. Muscle Nerve 16: 1232â1238.
Ionasescu VV, Searby C, Ionasescu R, Meschino W (1995): New point mutations and deletions of the connexin 32 gene in X-linked Charcot-Marie-Tooth neuropathy. Neuromusc Disord 5: 297â299.
Ionasescu VV, Trofatter J, Haines JL (1991): Heterogeneity in X-linked recessive Charcot-Marie-Tooth neuropathy. Am J Hum Genet 48: 1075â1083.
Ionasescu VV, Trofatter J, Haines JL, Summers AM, Ionasescu R, Searby C (1992): X-linked recessive CharcotMarie-Tooth neuropathy-clinical and genetic study. Muscle Nerve 15: 368â373.
Konishi T (1990): Dye coupling between mouse Schwann cells. Brain Res 508: 85â92.
Kumar NM, Gilula N (1992): Molecular biology and genetics of gap junction channels. Semin Cell Biol 3:3â16.
Latour P, Fabreguette A, Ressot C, Blanquet-Grossard F, Antoine JC, Calvas P, et al. (1997): New mutations in the X-linked form of Charcot-Marie-Tooth disease. Eur Neurol 37: 38â42.
Le Guern E, Ravise N, Gugenheim M, Vignal A, Penet C, Bouche P, Weissenbach J, Agid Y, Brice A (1994): Linkage analyses between dominant X-linked Charcot-Marie-Tooth disease, and 15 Xql 1-Xg21 microsatellites in a new large family: three new markers are closely linked to the gene. Neuromusc Disord 4: 463â469.
Lyon MF (1963): Gene action in the X-chromosome of the mouse. Nature 100: 372.
Magyar JP, Martini R, Ruelicke T, Aguzzi A, Adlkofer K, Dembic Z, Zielasek J, Toyka KV, Suter U (1996): Impaired differentiation of Schwann cells in transgenic mice with increased PMP22 gene dosage. J Neurosci 16: 5351â5360.
Meda P, Pepper MS, Traub O, Willecke K, Gros D, Beyer E, Nicholson B, Paul D. Orci L (1993): Differential expression of gap junction connexins in endocrine and exocrine glands. Endocrinol 133: 2371â2378.
Micevych PE, Abelson L (1991): Distribution of mRNAs coding for liver and heart gap junction proteins in the rat central nervous system. J Comp Neurol 305:96â118.
Mirsky R. Jessen KR (1996): Schwann cell development, differentiation and myelination. Curr Opin Neurobiol 6: 89â96.
Mostacciuolo ML, Muller E, Fardin P, Micaglio GF, Bardoni B, Guioli S, Camerino G, Danieli GA (1991): X-linked Charcot-Marie-Tooth disease: a linkage sudy in a large family by using 12 probes for the pericentromeric region. Hum Genet 87:23â27
Nave K-A, Boespflug-Tanguy O (1990): Developmental defects of myelin formation: from N-linked imitations to human dvsmvelinating diseases. Neuroscientist 2: 33â43.
Nelis E, Simokovic S, Timmerman V, Lofgrcn A, Backhovens H, De Hoghe P. Martin L Van Brocckhoven C (1997): Mutation analysis of the connexin32 (Cx32) gene in Charcot-Marie-Tooth neuropathy type i: identification of five new mutations. Hum Mutat 9: 47â52.
Nelis E, Van Broeckhoven C. co-authors (1996): Estimation of the mutation frequencies in Charcot-Marie-Tooth disease type I and hereditary neuropathy with liability to pressure palsies: a European collaborative study. Fur J Human Genet 4: 25â33.
Nelles E, Butzler C. Jung D. Temme A. Gabriel H-D, Dahl U, Traub O. Stumpel F. Jungermann K. Zielasek J. Toyka KV, Dermietzel R, Willecke K (1996): Defective propagation of signals generated be sympathetic nerve stimulation in the liver of connexin32-deficient mice. Proc Natl Acad Sci USA 93
Neuhaus IM, Bone L, Wang S, Ionasescu V, Werner R (1996): The human connexin32 gene is transcribed from two tissue-specific promoters. Biosci Reports 16: 239â248.
Neuhaus IM. Dahl G. Werner R (1995): Use of alternative promoters for tissue-specific expression of the gene coding for connexin32. Gene 158:257â262.
Nicholson B, Dermietzel R, Teplow D, Traub O, Willecke K, Revel J-P (1987): Two homologous protein components of hepatic gap junctions. Nature 329: 732â734.
Nicholson G, Nash J (1993): Intermediate nerve conduction velocities define X.-linked Charcot-Marie-Tooth neuropathy families. Neurology. 43: 2558â2564.
Omori Y, Mesnil M, Yamasaki H (1996): Connexin 32 mutations from X-linked Charcot-Marie-Tooth disease patients: functional defects and dominant negative effects. Mol Biol Cell 7: 907â916
Orth U. Fairweather N. Wexler MC. Schwinger E, Gal A (1994): X-linked dominant Charcot-Marie-Tooth neuropathy: saline-38-methionine substitution of connexin32. Hum Mol Genet 3:1699 âą1700.
Oterino A, Monzon Fl, Cabrera VM, Pinto F, Gonzalez A, Lavilla NR (1996): Arginme-164-tryptophan substitution in connexin32 associated with X linked dominant Charcot-Marie-Tooth disease.J Med Genet 33: 413â415.
Phillips LH, Kelly TE, Schnatterly P, Parker D (1985): Hereditary motor-sensory neuropathy (HMSN): possible X-linked dominant inheritance. Neurology 35: 498â502.
Rabadan-Diehl C, Dahl G, Werner R (1994): A connexin-32 mutation associated with Charcot-Marie-Tooth disease does not affect channel formation in oocytes. FEBS Lett 351: 90â94.
Ressot C, Latour P, Blanquet-Grossard F, Sturtz F, Duthel S. Battin J, Corbillon E, Ollagnon E, Serville F, Vandenberghe A, Dautigny A, Pham-Dinh D (1996): X-linked dominant Charcot-Marie-Tooth neuropathy (CMTX): new mutations in the connexin32 gene. Hum Genet 98: 172â175.
Reynolds ML, Woolf CJ (1993): Reciprocal Schwann cell-axon interactions. Curr Opin Neurobiol 3: 683â693.
Roa BB, Lupski JR (1994): Molecular genetics of Charcot-Marie-Tooth neuropathy. In Harris H and Hirschhorn L. âAdvances in Human Genetics.â New York: Plenum Press Div Plenum Publishing Corp, pp 117â152.
Rozear MP, Pericak-Vance MA, Fischbeck K, Stajich JIM, Gaskell PC Jr., Krendel DA. Graham DG. Dawson DV, Roses AD (1987): Hereditary motor and sensory neuropathy, X-linked: a half century follow-up. Neurology 37: 1460â1465.
Sandri C, Van Buren JM, Akert K (1982): Membrane morphology of the vertebrate nervous system. Prog Brain Res 46: 201â265.
Scherer SS (1996): Molecular specializations at nodes and paranodes in peripheral nerve. Microsc Res Tech 34: 452â61.
Scherer SS, Asbury AK (1997): Inherited axonal neuropathies and the molecular biology of peripheral neuropathies. In Rosenberg RN, Prusiner SB, DiMauro S and Barchi RL. âThe Molecular and Genetic Basis of Neurological Disease.â Butterworth-Heinemann pp 817â843.
Scherer SS, DeschĂ«nes SM, Xu Y-t, Grinspan JB, Fischbeck KH, Paul DL (1995): Connexin32 is a myelin-related protein in the PNS and CNS. J Neurosci 15: 8281â8294.
Schiavon F, Fracasso C, Mostacciuolo ML (1996): Novel missense mutation of the connexin 32 (GJB1) gene in X-linked dominant Charcot-Marie-Tooth neuropathy. Hum Mutat 8: 83â84.
Sereda M, Griffiths I, Puhlhofer A, Stewart H, Rossner MJ, Zimmermann F, Magyar JP, Schneider A, Hund E, Meinck HM, Suter U, Nave KA (1996): A transgenic rat model of Charcot-Marie-Tooth disease. Neuron 16: 1049â1060.
Skre H (1974): Genetic and clinical aspects of Charcot-Marie-Toothâs disease. Clin Genet 6: 98â118.
Sohl G, Gillen C, Bosse F, Gleichmann M, Muller HW, Willecke K (1996): A second alternative transcript of the gap junction gene connexin32 is expressed in murine Schwann cells and modulated in injured sciatic nerve. Eur J Cell Biol 69: 267â275.
Sorour E, Upadhyaya M (1995): Identification of seven novel mutations in peripheral myelin genes. Am J Hum Genet 57: A229.
Stauffer KA, Unwin N (1992): Structure of gap junction channels. Sem Cell Biol 3: 17â20.
Suter U, Snipes GJ (1995): Biology and genetics of hereditary motor and sensory neuropathies. Annu Rev Neuro-sci 18: 45â75.
Tan CC, Ainsworth PJ, Hahn AF, MacLeod PM (1996): Novel mutations in the connexin 32 gene associated with X-linked Charcot-Marie tooth disease. Hum Mutat 7: 167â171.
Tetzlaff W (1982): Tight junction contact events and temporary gap junctions in the sciatic nerve fibres of the chicken during Wallerian degeneration and subsequent regeneration. J Neurocytol 11: 839â358.
Timmerman V, Dejonghe P, Spoelders P, Simokovic S, Lofgren A, Nelis E, Vance J, Martin JJ, Van Broeckhoven C (1996): Linkage and mutation analysis of Charcot-Marie-Tooth neuropathy type 2 families with chromosomes 1p35-p36 and Xg13. Neurology 46: 1311â1318.
Webster HD, Schroder JM, Asbury AK, Adams RD (1967): The role of Schwann cells in the formation of âonion bulbsâ found in chronic neuropathies. J Neuropathol Exp Neurol 26: 276â299.
Woratz G (1964): Neurale Muskelatrophie mit Dominantem X-Chromosomalem Erbgang. Berlin: Akademie-Verlag, 99 p.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Science+Business Media New York
About this chapter
Cite this chapter
Scherer, S.S., Bone, L.J., DeschĂȘnes, S.M., Fischbeck, K., Balice-Gordon, R.J. (1997). The Role of the Gap Junction Protein Connexin32 in the Myelin Sheath. In: Juurlink, B.H.J., Devon, R.M., Doucette, J.R., Nazarali, A.J., Schreyer, D.J., Verge, V.M.K. (eds) Cell Biology and Pathology of Myelin. Altschul Symposia Series, vol 4. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-5949-8_9
Download citation
DOI: https://doi.org/10.1007/978-1-4615-5949-8_9
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-45595-7
Online ISBN: 978-1-4615-5949-8
eBook Packages: Springer Book Archive